Eplerenone NEW
| Price | $44 | $63 | $127 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-27 |
Product Details
| Product Name: Eplerenone | CAS No.: 107724-20-9 |
| Purity: 99.84% | Supply Ability: 10g |
| Release date: 2026/07/27 |
Product Introduction
Bioactivity
| Name | Eplerenone |
| Description | Eplerenone (CGP 30083) is an aldosterone receptor antagonist and potassium-sparing diuretic used in the therapy of hypertension. Eplerenone therapy has been associated with transient elevations in serum aminotransferase levels, but has yet to be linked to cases of clinically apparent drug induced liver disease. |
| In vitro | Eplerenone increases total vascular and luminal areas in swine without affecting the endothelial area. In canine models, it significantly reduces left ventricular end-diastolic wall stress. Eplerenone attenuates the rise in pulse pressure due to aldosterone (Aldo) in rats, normalizing the wall stress curve, mean cross-sectional area, and EIIIA fibronectin levels in Aldo-salt hypertensive rats. The compound upregulates diminished endothelial nitric oxide synthase mRNA in Dahl salt-sensitive hypertensive (DS) rats, markedly improving glomerulosclerosis and proteinuria. In mice, daily administration of 200 mg/kg of Eplerenone significantly lowers systolic and diastolic blood pressures compared to controls and increases serum phosphatase activity. |
| Storage | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Saline : 0.71 mg/mL (1.71 mM), Solution. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 1 mg/mL (2.41 mM), Sonication is recommended. DMSO : 7.14 mg/mL (17.23 mM), Sonication is recommended. |
| Keywords | specific | SC66110 | SC 66110 | MRA | Mineralocorticoid Receptor | Inhibitor | inhibit | hypertension | GlucocorticoidReceptor | Glucocorticoid Receptor | Eplerenone | Endogenous Metabolite | chronic systolic heart failure (HF) | CGP-30083 | CGP30083 | cardiovascular (CV) | atherosclerosis | aldosterone |
| Inhibitors Related | Sucrose | Aceglutamide | Nicotinamide riboside malate | L-Cysteine | D(+)-Raffinose pentahydrate | Guanidine hydrochloride | Guanidine thiocyanate | glycine | Malic acid | Glycerol | Thymidine | Gluconate Calcium |
| Related Compound Libraries | Bioactive Compound Library | ReFRAME Related Library | Glutamine Metabolism Compound Library | Toxic Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | Covalent Inhibitor Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $980.00 |
VIP3Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2026-09-04 | |
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-09-04 | ||
|
VIP3Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-08-25 | ||
| $301.00 |
VIP5Y
|
Hebei Dangtong Import and export Co LTD
|
2026-08-21 | |
|
VIP3Y
|
Hangzhou Hyper Chemicals Limited
|
2026-08-11 | ||
| $44.00 |
VIP7Y
|
TargetMol Chemicals Inc.
|
2026-07-27 | |
| $44.00 |
VIP3Y
|
TargetMol Chemicals Inc.
|
2026-07-27 | |
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-06-30 | ||
| $5.00 |
Wuhan JiyunZen Tech Co., Ltd.
|
2026-04-10 | ||
|
VIP6Y
|
Zhejiang J&C Biological Technology Co.,Limited
|
2025-12-25 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY